Artelo Biosciences
Price & Volume
Stats
See moreOpen | $0.71 |
Previous Close | $0.71 |
Day Range | $0.71-$0.72 |
52W Range | $0.66-$28.14 |
Market Cap | $3.2M |
Shares Short | 135,122 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$11.69 |
News
See moreYahoo Finance • 17 days ago
Artelo Biosciences Enrolls First Patient In Phase 2 Glaucoma Study Of ART27.13
Yahoo Finance • 17 days ago
Artelo Enrolls First Patient In Phase 2 DREAM Trial For ART27.13 In Treating Intralocular Pressure
Yahoo Finance • last month
Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions
Yahoo Finance • 3 months ago
Pre Market Movers: GNTA, HCWC, ZCMD Set The Path
About
CEO | Mr. Gregory D. Gorgas M.B.A. |
CFO | Mr. Mark E. Spring CPA |
Address | 505 Lomas Santa Fe, Solana Beach, CA, United States, 92075 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |